|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
ES2096590T3
(es)
|
1989-06-29 |
1997-03-16 |
Medarex Inc |
Reactivos biespecificos para la terapia del sida.
|
|
US5670617A
(en)
|
1989-12-21 |
1997-09-23 |
Biogen Inc |
Nucleic acid conjugates of tat-derived transport polypeptides
|
|
US5804604A
(en)
|
1989-12-21 |
1998-09-08 |
Biogen, Inc. |
Tat-derived transport polypeptides and fusion proteins
|
|
ES2087997T3
(es)
|
1990-01-12 |
1996-08-01 |
Cell Genesys Inc |
Generacion de anticuerpos xenogenicos.
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
ES2108048T3
(es)
|
1990-08-29 |
1997-12-16 |
Genpharm Int |
Produccion y utilizacion de animales inferiores transgenicos capaces de producir anticuerpos heterologos.
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
JPH06507398A
(ja)
|
1991-05-14 |
1994-08-25 |
リプリジェン コーポレーション |
Ｈｉｖ感染治療のための異種複合抗体
|
|
WO1993008829A1
(en)
|
1991-11-04 |
1993-05-13 |
The Regents Of The University Of California |
Compositions that mediate killing of hiv-infected cells
|
|
JPH07509137A
(ja)
|
1992-07-24 |
1995-10-12 |
セル ジェネシス，インク． |
異種抗体の生産
|
|
EP1005870B1
(en)
|
1992-11-13 |
2009-01-21 |
Biogen Idec Inc. |
Therapeutic application of chimeric antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
EP0822830B1
(en)
|
1995-04-27 |
2008-04-02 |
Amgen Fremont Inc. |
Human anti-IL-8 antibodies, derived from immunized xenomice
|
|
CA2219486A1
(en)
|
1995-04-28 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
EP0845043B1
(en)
|
1995-07-28 |
2007-06-27 |
Marie Curie Cancer Care |
Transport proteins and their uses
|
|
EP0799422A1
(en)
|
1995-10-24 |
1997-10-08 |
Sangstat Medical Corporation |
Anti alpha-galactosyl screening technique
|
|
US5965703A
(en)
|
1996-09-20 |
1999-10-12 |
Idun Pharmaceuticals |
Human bad polypeptides, encoding nucleic acids and methods of use
|
|
US5916771A
(en)
|
1996-10-11 |
1999-06-29 |
Abgenix, Inc. |
Production of a multimeric protein by cell fusion method
|
|
US7064193B1
(en)
|
1997-09-17 |
2006-06-20 |
The Walter And Eliza Hall Institute Of Medical Research |
Therapeutic molecules
|
|
US20020029391A1
(en)
|
1998-04-15 |
2002-03-07 |
Claude Geoffrey Davis |
Epitope-driven human antibody production and gene expression profiling
|
|
EP1210098A1
(en)
|
1999-04-07 |
2002-06-05 |
Thomas Jefferson University |
Enhancement of peptide cellular uptake
|
|
AU6906100A
(en)
|
1999-08-16 |
2001-03-13 |
Government of The United States of America, as represented by The Secretary Department of Health & Human Services, The National Institutes of Health, The |
Receptor-mediated uptake of an extracellular bcl-xl fusion protein inhibits apoptosis
|
|
WO2002020568A2
(en)
|
2000-09-06 |
2002-03-14 |
Abbott Laboratories |
Mutant peptides derived from bad and their use to identify substances which bind to a member of the bcl-2 family of proteins
|
|
WO2002069995A2
(en)
|
2001-02-16 |
2002-09-12 |
Medical College Of Georgia Research Institute, Inc. |
Use of trail and antiprogestins for treating cancer
|
|
AU2002361589A1
(en)
|
2001-11-06 |
2003-05-19 |
Enanta Pharmaceuticals, Inc. |
Methods and compositions for identifying peptide aptamers capable of altering a cell phenotype
|
|
EP1455819A1
(en)
|
2001-12-21 |
2004-09-15 |
Arius Research, Inc. |
Individualized anti-cancer antibodies
|
|
WO2004022580A2
(en)
|
2002-09-09 |
2004-03-18 |
Dana-Farber Cancer Institute, Inc. |
Bh3 peptides and method of use thereof
|
|
US20070032417A1
(en)
|
2002-12-24 |
2007-02-08 |
Walter And Eliza Hall Institute Of Medical Research |
Peptides and therapeutic uses thereof
|
|
AU2004221348A1
(en)
|
2003-03-19 |
2004-09-30 |
Alfa Wassermann, Inc. |
Separation and accumulation of subcellular components, and proteins derived therefrom
|
|
PL1680443T3
(pl)
|
2003-11-05 |
2014-02-28 |
Dana Farber Cancer Inst Inc |
Stabilizowane alfa-helikalne peptydy i ich zastosowanie
|
|
WO2006069186A2
(en)
*
|
2004-12-22 |
2006-06-29 |
The Ohio State Research Foundation |
Small molecule bcl-xl/bcl-2 binding inhibitors
|
|
JP2005130867A
(ja)
|
2005-02-16 |
2005-05-26 |
Mitokor |
ミトコンドリア内カルシウムを使用するスクリーニングアッセイ
|
|
WO2006099667A1
(en)
|
2005-03-21 |
2006-09-28 |
The Walter And Eliza Hall Institute Of Medical Research |
Prophylactic and therapeutic agents and uses therefor
|
|
US20070027175A1
(en)
|
2005-07-27 |
2007-02-01 |
Shaughnessy John Jr |
Antineoplastic activities of ellipticine and its derivatives
|
|
EP2008106A2
(en)
|
2006-03-31 |
2008-12-31 |
Dana-Farber Cancer Institute |
Methods of determining cellular chemosensitivity
|
|
US8518635B2
(en)
|
2006-06-12 |
2013-08-27 |
The J. David Gladstone Institutes |
Regulation of protein activity by reversible acetylation
|
|
KR100786759B1
(ko)
|
2006-07-07 |
2007-12-18 |
김현기 |
Ｈｃｃｒ-1을 포함하는 유방암 예후 마커 및 비만 유도조성물
|
|
US9360473B2
(en)
*
|
2006-08-16 |
2016-06-07 |
Eutropics Pharmaceuticals, Inc. |
Assay system to identify therapeutic agents
|
|
WO2008152405A2
(en)
|
2007-06-15 |
2008-12-18 |
The Queen's University Of Belfast |
Protein complexes comprising bh3 peptides and voltage dependent anion channel (vdac) peptides as well as uses thereof for the treatment of proliferative diseases
|
|
JP2011501731A
(ja)
|
2007-09-10 |
2011-01-13 |
ユニバーシティ オブ マサチューセッツ |
ミトコンドリア標的化抗腫瘍剤
|
|
WO2009042237A2
(en)
|
2007-09-26 |
2009-04-02 |
Dana Farber Cancer Institute |
Methods and compositions for modulating bcl-2 family polypeptides
|
|
JP2009240173A
(ja)
|
2008-03-28 |
2009-10-22 |
Univ Of Tokushima |
パーキン蛋白の新規糖化因子
|
|
EP4043552A1
(en)
|
2009-06-11 |
2022-08-17 |
Minerva Biotechnologies Corporation |
Methods for culturing stem and progenitor cells
|
|
WO2010147961A1
(en)
|
2009-06-15 |
2010-12-23 |
Precision Therapeutics, Inc. |
Methods and markers for predicting responses to chemotherapy
|
|
US20130122492A1
(en)
|
2011-11-14 |
2013-05-16 |
Kellbenx Inc. |
Detection, isolation and analysis of rare cells in biological fluids
|
|
CN104541170A
(zh)
|
2012-05-10 |
2015-04-22 |
尤特罗皮克斯制药股份有限公司 |
对癌症的代理功能性诊断测试
|
|
WO2013188978A1
(en)
|
2012-06-20 |
2013-12-27 |
Cytospan Technologies Corporation |
Apparatus and method for quantification of replicative lifespan and observation of senescene
|
|
EP2898327A1
(en)
|
2012-09-19 |
2015-07-29 |
Dana-Farber Cancer Institute, Inc. |
Dynamic bh3 profiling
|
|
JP6327662B2
(ja)
|
2012-09-26 |
2018-05-23 |
学校法人藤田学園 |
細胞表面タンパクを抗原とする抗体を測定する方法
|
|
JP2016526892A
(ja)
|
2013-07-18 |
2016-09-08 |
ユートロピクス ファーマシューティカルズ， インコーポレイテッド |
示差的ｂｈ３ミトコンドリアプロファイリング
|
|
CA2922503C
(en)
|
2013-09-19 |
2021-10-26 |
Dana-Farber Cancer Institute, Inc. |
Methods of bh3 profiling
|
|
JP6802185B2
(ja)
|
2015-04-27 |
2020-12-16 |
デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド |
ハイスループットｂｈ３プロファイリング：少量の細胞でのｂｈ３プロファイルのための迅速かつ拡大縮小可能な技術
|
|
US11092602B2
(en)
|
2015-07-06 |
2021-08-17 |
Whitehead Institute For Biomedical Research |
Methods and compositions relating to proteasome inhibitor resistance
|
|
WO2020176689A1
(en)
|
2019-02-26 |
2020-09-03 |
Dana-Farber Cancer Institute, Inc. |
Live cell imaging dynamic bh3 profiling
|